Clinical Trial Update: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of off-the-shelf expanded cord blood cells to augment cord blood transplant in patients with various hematologic maligna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Accelerated Phase Chronic Myelogenous Leukemia
• Acute Myeloid Leukemia in Remission
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Abnormalities
• Acute Myeloid Leukemia with Del
• Acute Myeloid Leukemia with Inv
• Anemia
• Anemia with Excess Blasts
• Anemia with Excess Blasts in Transformation
• Childhood Acute Lymphoblastic Leukemia in Remission
• Childhood Acute Myeloid Leukemia in Remission
• Childhood Chronic Myelogenous Leukemia
• Childhood Myelodysplastic Syndromes
• De Novo Myelodysplastic Syndromes
• Myelodysplastic Syndromes
• Phase Chronic Myelogenous Leukemia
• Previously Treated Myelodysplastic Syndromes
• Relapsing Chronic Myelogenous Leukemia

Drugs mentioned

• Off-the-shelf expanded cord blood cells

Snippet

Sponsor: Nohla Therapeutics, Inc. | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission | Phase 2 | Status: COMPLETED